173 related articles for article (PubMed ID: 30281616)
1. HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination.
Valencia La Rosa J; Ryan P; Alvaro-Meca A; Troya J; Cuevas G; Gutiérrez J; Moreno S
PLoS One; 2018; 13(10):e0204795. PubMed ID: 30281616
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention.
Artenie AA; Roy É; Zang G; Jutras-Aswad D; Bamvita JM; Puzhko S; Daniel M; Bruneau J
Int J Drug Policy; 2015 Oct; 26(10):970-5. PubMed ID: 26005038
[TBL] [Abstract][Full Text] [Related]
3. High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units.
Valencia J; Alvaro-Meca A; Troya J; Cuevas G; Gutiérrez J; Morro A; Alvarez J; Pulido L; Cañamares I; Escobar I; Moreno S; Ryan P
Int J Drug Policy; 2019 Oct; 72():181-188. PubMed ID: 31253391
[TBL] [Abstract][Full Text] [Related]
4. High HIV seroconversion rate in hepatitis C virus-infected drug users followed in a harm reduction unit: a lost opportunity for preexposure prophylaxis.
Valencia J; Ryan P; Alvaro-Meca A; Troya J; Gutierrez J; Cuevas G; Moreno S
AIDS; 2018 Jun; 32(9):1157-1163. PubMed ID: 29561294
[TBL] [Abstract][Full Text] [Related]
5. High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes.
Vallejo F; Barrio G; Brugal MT; Pulido J; Toro C; Sordo L; Espelt A; Bravo MJ;
J Epidemiol Community Health; 2015 Jun; 69(6):599-603. PubMed ID: 25870164
[TBL] [Abstract][Full Text] [Related]
6. Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada.
Jacka B; Roy É; Høj S; Minoyan N; Artenie AA; Zang G; Jutras-Aswad D; Bruneau J
J Viral Hepat; 2019 Dec; 26(12):1413-1422. PubMed ID: 31433888
[TBL] [Abstract][Full Text] [Related]
7. [Incidence and risk factors of HCV infection in a cohort of intravenous drug users in the North and East of France].
Bruandet A; Lucidarme D; Decoster A; Ilef D; Harbonnier J; Jacob C; Delamare C; Cyran C; Van Hoenacker AF; Frémaux D; Josse P; Emmanuelli J; Le Strat Y; Filoche B; Desenclos JC
Rev Epidemiol Sante Publique; 2006 Jul; 54 Spec No 1():1S15-1S22. PubMed ID: 17073126
[TBL] [Abstract][Full Text] [Related]
8. Low risk for hepatitis C seroconversion in methadone maintenance treatment.
Peles E; Schreiber S; Rados V; Adelson M
J Addict Med; 2011 Sep; 5(3):214-20. PubMed ID: 21844836
[TBL] [Abstract][Full Text] [Related]
9. Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy.
Spada E; Rezza G; Garbuglia AR; Lombardo FL; Zuccaro O; Menniti Ippolito F; Cupellaro E; Capone S; Capobianchi MR; Nicosia A; Cortese R; Folgori A; Mele A;
J Urban Health; 2018 Feb; 95(1):99-110. PubMed ID: 29204843
[TBL] [Abstract][Full Text] [Related]
10. HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection.
Bravo MJ; Vallejo F; Barrio G; Brugal MT; Molist G; Pulido J; Sordo L; de la Fuente L;
Int J Drug Policy; 2012 Sep; 23(5):415-9. PubMed ID: 22421554
[TBL] [Abstract][Full Text] [Related]
11. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
[TBL] [Abstract][Full Text] [Related]
12. Benzodiazepine Use and Hepatitis C Seroconversion in a Cohort of Persons Who Inject Drugs.
Bach P; Walton G; Hayashi K; Milloy MJ; Dong H; Kerr T; Montaner J; Wood E
Am J Public Health; 2016 Jun; 106(6):1067-72. PubMed ID: 26985601
[TBL] [Abstract][Full Text] [Related]
13. A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs.
Hope VD; Harris RJ; Vickerman P; Platt L; Shute J; Cullen KJ; Ijaz S; Mandal S; Ncube F; Desai M; Parry JV
Euro Surveill; 2018 Nov; 23(47):. PubMed ID: 30482265
[TBL] [Abstract][Full Text] [Related]
14. Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence.
Rezza G; Sagliocca L; Zaccarelli M; Nespoli M; Siconolfi M; Baldassarre C
Scand J Infect Dis; 1996; 28(1):27-9. PubMed ID: 9122628
[TBL] [Abstract][Full Text] [Related]
15. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
Allen EJ; Palmateer NE; Hutchinson SJ; Cameron S; Goldberg DJ; Taylor A
Int J Drug Policy; 2012 Sep; 23(5):346-52. PubMed ID: 22940142
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C in a Mobile Low-Threshold Methadone Program.
Silva MJ; Pereira C; Loureiro R; Balsa C; Lopes P; Água-Doce I; Belo E; Martins HC; Coutinho R; Pádua E
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):657-662. PubMed ID: 28151750
[TBL] [Abstract][Full Text] [Related]
17. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.
Patrick DM; Tyndall MW; Cornelisse PG; Li K; Sherlock CH; Rekart ML; Strathdee SA; Currie SL; Schechter MT; O'Shaughnessy MV
CMAJ; 2001 Oct; 165(7):889-95. PubMed ID: 11599327
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C Virus Prevalence and Incidence in a Large Nationwide Sample of Patients in Opioid Substitution Treatment in Germany: A Prospective Cohort Study.
Schulte B; Schmidt CS; Strada L; Rosenkranz M; Schäfer I; Verthein U; Reimer J
Clin Infect Dis; 2020 May; 70(10):2199-2205. PubMed ID: 31631215
[TBL] [Abstract][Full Text] [Related]
19. Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study.
White B; Dore GJ; Lloyd AR; Rawlinson WD; Maher L
Med J Aust; 2014 Sep; 201(6):326-9. PubMed ID: 25222455
[TBL] [Abstract][Full Text] [Related]
20. Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada.
Fortier E; Artenie AA; Zang G; Jutras-Aswad D; Roy É; Grebely J; Bruneau J
Addiction; 2019 Aug; 114(8):1495-1503. PubMed ID: 30957310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
